SFX by Ex Libris Inc.

Title:	Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Source:	Nature Genetics [1061-4036] Bueno, Raphael yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gill, Nicole J. "Loss of expression of BAP1 predicts longer survival in mesothelioma." Pathology 47.4 (2015): 302-7.
description	2.	Ujiie, H. "The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers." Oncoimmunology 4.6 (2015).
description	3.	Kolodney, S. "Mutational Landscape of Basal Cell Carcinomas by Whole Exome Sequencing." Journal of investigative dermatology 134.1 (2013): 213-20.
description	4.	Frei, C. "Pleural mesothelioma side populations have a precursor phenotype." Carcinogenesis 32.9 (2011): 1324-1332.
description	5.	Rodrıguez Gonzalez, Dana A M G. "The challenge of gene expression profiling in heterogeneous clinical samples." Methods 59.1 (2012): 47-58.
description	6.	Pastorino, S. "Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma." Oncotarget 7.37 (2016): 59314-59321.
description	7.	Sacco, Judy J. "Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors." Oncotarget 6.15 (2015): 1-15.
description	8.	Mori, T. "Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma." Cancer science 106.9 (2015): 1118-1129.
description	9.	Liu, H. "Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma." Tumor biology 36.10 (2015): 7375-84.
description	10.	Read, J. "Melanoma genetics." Journal of medical genetics Publish Ahead of Print.1 (2015): 1-14.
description	11.	Marušić, Z. "Histomorphologic Spectrum Of Bap1 Negative Melanocytic Neoplasms In A Family With Bap1-Associated Cancer Susceptibility Syndrome." Journal of cutaneous pathology 42.6 (2015): 406-12.
description	12.	Stacey, Simon N. "New basal cell carcinoma susceptibility loci." Nature communications 6.1 (2015): 6825-6825.
description	13.	Wheeler, Kyle J. "Mutational landscape of aggressive cutaneous squamous cell carcinoma." Clinical cancer research 20.24 (2014): 6582-92.
description	14.	Martowicz, A. "EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth." Molecular cancer (2013): 56-56.
description	15.	Wang, C. "Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer." Medical hypotheses 80.6 (2013): 833-6.
description	16.	Dundas, J. "Reference genes for measuring mRNA expression." Theory in biosciences 131.4 (2012): 215-223.
description	17.	Bender, R. "Molecular Classification of Unknown Primary Cancer." Seminars in oncology 36.1 (2009): 38-43.
description	18.	Xie, J. "Activating Smoothened mutations in sporadic basal-cell carcinoma." Nature 391.6662 (1998): 90-2.
description	19.	Crowson, A Neil N. "Basal cell carcinoma: biology, morphology and clinical implications." Modern pathology 19.S2 (2006): 127-47.
description	20.	Ordóñez, Nelson G G. "Immunohistochemical diagnosis of epithelioid mesothelioma: an update." Archives of pathology & laboratory medicine 129.11: 1407-1414.